Editorial
The "angioplastically correct" follow up strategy after stent implantation
| The first 150 words of the full text of this article appear below. |
Over
the last few years, the technique of percutaneous transluminal coronary
angioplasty (PTCA) has undergone great change. The use of atherectomy
has become marginal, and stent implantation almost systematic,
justified by both a better outcome and a better cost:effectiveness
ratio.1 2 Even the provisional use of stents seems to be
less effective and more expensive than systematic stenting.3 Continuing advances in technology have more or
less made the preliminary balloon predilatation unnecessary, leading to
a technique now known as "direct stenting". In this way, coronary angioplasty can increasingly be classified as simply stent
implantation, a simple, safe, and rapid procedure. Furthermore, a
consensus has progressively appeared regarding the follow up strategy
and the indications for target vessel revascularisation (TVR), no longer based on the angiographic six month control, but rather only on
symptoms and non-invasive detection of ischaemia, constituting an
"angioplastically correct" follow up strategy. The difficulty of
effectively treating in-stent
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
